Sarda Proteins Limited’s board has approved a proposal to change the company's name, subject to approval by the Central Registration Centre (CRC), Ministry of Corporate Affairs. The decision, taken during a meeting held on July 4, 2026, includes the consequent alteration of the Memorandum of Association and Articles of Association of the company. This strategic move requires regulatory consent before the new name can be adopted officially.

The board meeting commenced at 3:00 p.m. and concluded at 5:40 p.m. at the company's Registered Office. Managing Director Shirish Dhirajlal Savaliya oversaw the proceedings, which included this specific agenda item that was initially omitted in the earlier outcome filing submitted on July 4, 2026.

The revised disclosure was submitted to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company requested the exchange to record this additional agenda item alongside other approvals passed during the July 4 meeting.

Key Details of the Proposal

The alteration of the Memorandum of Association and Articles of Association is a standard procedural requirement when a company undergoes a name change. The final name will be determined based on the approval granted by the Central Registration Centre.

Sarda Proteins has expanded the agenda for its upcoming Extraordinary General Meeting (EGM) to include the appointment of a statutory auditor and the regularization of a woman independent director. The meeting is scheduled for July 30, 2026, at 11:00 A.M. via Video Conferencing. These additions, approved by the Board on July 15, 2026, require shareholder consent to finalize the appointments and ensure compliance with the Companies Act, 2013.

Statutory Auditor Appointment

The company proposes appointing M/s A H Mandaliya & Associates (firm registration number 022073N) to fill a casual vacancy caused by the resignation of the previous auditor. This appointment, recommended by the Board on November 26, 2025, will be effective from the conclusion of the EGM. The firm will conduct the statutory audit for the period ended March 31, 2026.

Shareholders are also asked to approve the appointment of M/s A H Mandaliya & Associates for the first term of five years, commencing from the conclusion of this EGM until the Annual General Meeting for FY 2030-31. The auditors have confirmed their eligibility and that their appointment falls within the limits prescribed under Section 141 of the Companies Act, 2013.

Independent Director Regularization

The EGM agenda includes the regularization of Ms. Minal Surendra Jain (DIN: 11822395) as a Woman Independent Director. She was initially appointed as an Additional Director by the Board on July 15, 2026. Upon shareholder approval, she will hold office for a term of five consecutive years effective from July 15, 2026.

Ms. Jain, aged 26, is a graduate and a semi-qualified Company Secretary with expertise in corporate compliance, governance, and regulatory reporting. She has confirmed that she meets the independence criteria specified under Section 146(9) of the Companies Act, 2013. None of the other directors or key managerial personnel are interested in these resolutions.

Key Agenda Items